MBX Biosciences CMO expands holdings through significant stock options acquisition filed recently.

#MBXBiosciences #StockOptions #InsiderTrading #BiotechStocks

https://meyka.com/blog/mbx-biosciences-cmo-acquires-55k-stock-options-on-may-8-2026-1205/

MBX Biosciences CMO Acquires 55K Stock Options on May 8, 2026 | Meyka

MBX CMO Azoulay Salomon acquired 55,000 stock options valued at $575,300 on May 8, 2026, per SEC filing insider transaction disclosure.